CSIMarket


10x Genomics Inc   (TXG)
Other Ticker:  
 


 

10x Genomics Inc

TXG's Financial Statements and Analysis



10x Genomics Inc narrowed I. Quarter net loss per share of $-0.38 compare to net loss per share of $-3.87 recorded in the same quarter a year ago a decrease compare to $-0.15 realized in previous quarter.


I. Quarter
Earnings Per Share Revenues
$ -0.38 $  114 Mill
$+3.49     $+2M     +2.03 %



10x Genomics Inc 's Revenue rose by 2.03 % in I. Quarter (Mar 31 2022) year on year, to $114 million and declined by -8.62 % sequentially.


10x Genomics Inc is Expected to report next financial results on November 04, 2022.

More on TXG's Income Statement



10x Genomics Inc 's in I. Quarter recorded net loss of $-42.413 million, an improvement compare to net loss of $-415.573 million in IV. Quarter a year ago.

Sequentially net loss advanced

More on TXG's Growth

Inventories grew by 112.61 % to $64 million from IV. Quarter a year ago, sequentially inventories rose by 24.55 %. In I. Quarter company's net cash and cash equivalents decreased by $-276 million, capital expenditures fell by 26.36%, to $-28 millions compare to same quarter a year ago and fell by 39.10% from III. Quarter (Sep 30 2021).

More on TXG's Cash flow Statement


10x Genomics Inc does not pay out common stock dividend.

In trailing twelve-month period 10x Genomics Inc payed $ -0.42 cash per share, on a free-cash flow basis .

Book value fell by -1.06 % sequentially to $7.14 per share, -10.33% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 6.88 per share from $ 7.18.

Company issued 2.09 million shares or 1.89 % in I. Quarter.


More on TXG's Dividends

 Market Capitalization (Millions) 5,449
 Shares Outstanding (Millions) 113
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 461
 Net Income (TTM) (Millions $) -82
 Cash Flow (TTM) (Millions $) -356
 Capital Exp. (TTM) (Millions $) -102
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




10x Genomics Inc does not pay out common stock dividend.

In trailing twelve-month period 10x Genomics Inc payed $ -0.42 cash per share, on a free-cash flow basis .

Book value fell by -1.06 % sequentially to $7.14 per share, -10.33% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 6.88 per share from $ 7.18.

Company issued 2.09 million shares or 1.89 % in I. Quarter.


More on TXG's Balance Sheets

 Market Capitalization (Millions) 5,449
 Shares Outstanding (Millions) 113
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 461
 Net Income (TTM) (Millions $) -82
 Cash Flow (TTM) (Millions $) -356
 Capital Exp. (TTM) (Millions $) -102
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EXTN's Profile

Stock Price

EXTN's Financials

Business Description

Fundamentals

Charts & Quotes

EXTN's News

Suppliers

EXTN's Competitors

Customers & Markets

Economic Indicators

EXTN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071